期刊文献+

霉酚酸酯羟丙基-β-环糊精包合物的制备

Preparation of Mycophenolate Mofetil Hydroxypropyl-β-cyclodextrin Inclusion Complexes
下载PDF
导出
摘要 目的:优化霉酚酸酯羟丙基-β-环糊精(HP-β-CD)包合物的包合工艺。方法:选用溶液-搅拌法制备包合物,采用正交试验来筛选影响HP-β-CD包合的主要因素,即HP-β-CD与药物的比例、包合温度、包合时间和搅拌速度,并以包封率和回收率为考察指标进行优选制备工艺,通过DSC验证包合物。结果:霉酚酸酯HP-β-CD的最佳包合条件为:HP-β-CD与药物配比为1:1,包合温度为80℃,包合时间为3h,搅拌速度为400 r.min^(-1)时,霉酚酸酯HP-β-CD包合物的包合工艺最佳。结论:霉酚酸酯羟丙基-β-环糊精(HP-β-CD)包合物的制备方法简便、可靠,并可大大提高霉酚酸酯的溶解度。 Objective: To optimize preparation process of mycophenolate mofetil hydroxypropyl -β- cyclodextrin ( HP-β-CD) inclusion complexes. Method: Inclusion complexes were prepared by solution-stirring methods. The optimum clathration condition was selected by orthogonal test with the ratio of HP-β-CD to mycophenolate mofetil, the clathration times and stirring speed as factors. And the encapsulation and clathration recovery were used as indexes. Result: The optimum preparation condition was as follows : the ratio of HP-β-CD to mycophenolate mofetil was 1: 1, the inclusion temperature was 80℃ , the inclusion time was 3h, and the stirring speed was 400 r. min ^- 1. Conclusion : The method of preparation of mycophenolate mofetil hydroxypropyl -β- eyclodextrin inclusion complex is convenient and reliable, and it can apparently improve the solubility of myeophenolate mofetil.
作者 杜蓉 黄军
出处 《中国药师》 CAS 2009年第8期1056-1058,共3页 China Pharmacist
关键词 霉酚酸酯 羟丙基-Β-环糊精 包合物 正交试验 Mycophenolate mofetil Hydroxypropyl-β-cyclodextrin Inclusion complexation Orthogonal test
  • 相关文献

参考文献4

二级参考文献30

  • 1武雪芬,郑晓珂,姚宏建,费娜.丹皮酚包合物的热稳定性考察和形成常数测定[J].中国中药杂志,2005,30(7):501-503. 被引量:15
  • 2张传海,徐飞.抗真菌新药伏立康唑[J].社区医学杂志,2005,3(11):30-31. 被引量:5
  • 3曾玲,刘宁,傅建.HPLC法测定依诺沙星软膏的含量[J].中国抗生素杂志,1997,22(2):153-154. 被引量:5
  • 4Javitt JC,Javitt NB,McDonnell P.Topical compositions for the eye comprsing a beta-cyclodextrin derivative and a carconic anhydlicarase inhibitor [P].WO:94/15582,1994-06-12.
  • 5Rojanasakul Y,Robinson JR.Transport mechanisms of the cornea: characterization of barrier permselectivity [J].Int J Pharm,1989,55:237-246.
  • 6Loftsson I,Stefànsson E.Effect of cyclodextrins on topical drug delivery to the eye [J].Drug Devel Ind Pharm Sci,1997,23:473-481.
  • 7Thorsteinn Loftsson,Stefànsson E,Kristinsson JK,et al.Topically effective acetazolamide eye-solution in man [J].Pharm Sci,1996,6:277-279.
  • 8Loftssona T,Jārvinen T.Cyclodextrins in ophthaic drug delivery [J].Adv Drug Del Rev,1999,36:59-79.
  • 9Saettone MF,Chetoni R.Evaluation of ocular permeation enhancers:in vitro effects on corneal transport of four β-blockers,and in vitro/in vivo toxic activity [J].Int J Pharm,1996,142:103-113.
  • 10Loftsson T, Stefánsson E. Cyclodextrins in eye drop formulations: enhanced topical delivery of corticostemids to the eye [ J ]. Acta Ophthalmol Scand, 2002, 80(2):144- 150.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部